These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Comparison of the effects of cholestyramine and aluminium hydroxide on the biliary bile acid excretion in rats. An experimental model for the depletion of bile acids in bile. Gregus Z; Barth A; Fischer E; Zaumseil J; Klinger W; Varga F Acta Biol Med Ger; 1980; 39(6):705-9. PubMed ID: 7456933 [TBL] [Abstract][Full Text] [Related]
7. Value of bile-acid binding agents in post-vagotomy diarrhoea. Taylor TV; Lambert ME; Torrance HB Lancet; 1978 Mar; 1(8065):635-6. PubMed ID: 76170 [TBL] [Abstract][Full Text] [Related]
8. [Role of bile acids in the development of peptic lesions. Studies on the bile acid-binding capacity of a new kind of antacid]. Kurtz W Fortschr Med; 1991 Oct; 109(29):592-4. PubMed ID: 1783351 [TBL] [Abstract][Full Text] [Related]
9. [The effect of pH and amount of antacids on bile acid binding in a quasi-natural reflux milieu]. Kurtz W; Güldütuna S; Leuschner U Z Gastroenterol; 1991 May; 29(5):237-41. PubMed ID: 1950032 [TBL] [Abstract][Full Text] [Related]
10. The ability of antacids and cholestyramine to bind bile acids: effect of pH. Mangnall YF; Smythe A; Johnson AG Scand J Gastroenterol; 1986 Sep; 21(7):789-94. PubMed ID: 3775246 [TBL] [Abstract][Full Text] [Related]
11. [Binding of bile salts and lysolecithin by various antacids in biological media]. Guthauser UJ; Häcki WH Schweiz Med Wochenschr; 1987 Feb; 117(9):322-7. PubMed ID: 3563454 [TBL] [Abstract][Full Text] [Related]
12. [Influence of pH in the adsorption capacity of bile salts and lysolecithins in vitro by antacids containing clay and/or aluminum]. Vatier J; Olivier JF; Vitre MT; Papazian A Gastroenterol Clin Biol; 1989 May; 13(5):445-51. PubMed ID: 2753281 [TBL] [Abstract][Full Text] [Related]
13. Adsorption of bile acids and lysolecithin by antacids. Begemann F; Schumpelick V; Bandomer G Scand J Gastroenterol Suppl; 1981; 67():191-3. PubMed ID: 6941407 [TBL] [Abstract][Full Text] [Related]
15. Comparison of antacids on the binding of bile salts. Cousar GD; Gadacz TR Arch Surg; 1984 Sep; 119(9):1018-20. PubMed ID: 6477113 [TBL] [Abstract][Full Text] [Related]
16. [Neutralizing capacity, pepsin inactivation and binding to bile acids and lysolecithin of the antacid magaldrate (author's transl)]. Baur C; Becker A; Linder R; Schwan T Arzneimittelforschung; 1981; 31(3):504-7. PubMed ID: 6784737 [TBL] [Abstract][Full Text] [Related]
17. Protective action of almagate against bile-facilitated gastric ulceration in the pylorus-ligated (Shay) rat. Llupiá J; Lumachi B; Beckett PR; Roberts DJ Arzneimittelforschung; 1984; 34(10A):1373-5. PubMed ID: 6548924 [TBL] [Abstract][Full Text] [Related]
18. Bile salt binding by maalox, sucralfate, and meciadanol: in vitro and clinical comparisons. Lipsett P; Gadacz TR J Surg Res; 1989 Nov; 47(5):403-6. PubMed ID: 2682004 [TBL] [Abstract][Full Text] [Related]
19. Double-blind trial of cholestyramine in post-vagotomy diarrhoea. Duncombe VM; Bolin TD; Davis AE Gut; 1977 Jul; 18(7):531-5. PubMed ID: 326641 [TBL] [Abstract][Full Text] [Related]
20. Effect of cholestyramine on the symptoms of reflux gastritis. A randomized, double blind, crossover study. Meshkinpour H; Elashoff J; Stewart H; Sturdevant RA Gastroenterology; 1977 Sep; 73(3):441-3. PubMed ID: 330302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]